Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Lilly Announces Webcast to Discuss World Conference on Lung Cancer Presentation

INDIANAPOLIS, Aug. 19, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, September 9, 2019 to discuss data presented for its RET-Inhibitor, LOXO-292, at the 20th meeting of the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer in Barcelona, Spain. Remarks will focus on registrational results from the LIBRETTO-001 trial, a Phase 1/2 trial of LOXO-292 in patients with RET fusion-positive lung cancers. The webcast will begin at 7:00 p.m. Central European Time, or 1:00 p.m. Eastern Time.

Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/events.cfm. A replay will also be available on the website following the conference call.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY   

Refer to:

Mark Taylor; mark.taylor@lilly.com; (317) 276-5795 (Media)

Kevin Hern; hern_kevin_r@lilly.com; (317) 277-1838 (Investors)


Eli Lilly and Company logo. (PRNewsfoto/Eli Lilly and Company)


SOURCE Eli Lilly and Company

These press releases may also interest you

at 05:05
September 23, 2019 New report shows how to address the challenges of implementing digital health technology ? a catalyst for achieving Universal Health Coverage (UHC)Philips Chief Medical Officer Jan Kimpen discusses the creation of enabling...

at 05:05
The global healthcare interoperability solutions market size is expected to reach USD 4.7 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 13.0% during the forecast period. Rising focus on patient-centric...

at 04:05
Clovis Oncology, Inc. has entered into a global licensing and collaboration agreement with 3B Pharmaceuticals GmbH (3BP), a private German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications...

at 04:00
To raise the levels of productivity, efficiency and quality of performance in the provision of health services in hospitals; the Saudi Ministry of Health (MOH) has launched "Ada'a Health", a program that paves the way for achieving health goals of...

at 04:00
The Revivent TCtm System has continued to deliver impressive results when evaluating post-market data in Europe.  The last 35 consecutive cases have resulted in a 34% improvement in ejection fraction (EF), 37% left ventricular volume reduction, zero...

at 04:00
Both the career fair and seminar are open to residents and fellows, as well as practicing physicians, nurse practitioners and physician assistants. The casual, family-friendly environment provides a chance for physicians and advanced practice...

News published on 19 august 2019 at 16:15 and distributed by: